ProKidney Corp (NASDAQ: PROK) is 59.55% higher on its value in year-to-date trading and has touched a low of $1.12 and a high of $13.51 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The PROK stock was last observed hovering at around $2.72 in the last trading session, with the day’s gains setting it 0.12%.
Currently trading at $2.84, the stock is 77.81% and 87.03% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.43 million and changing 4.41% at the moment leaves the stock -33.87% off its SMA200. PROK registered -77.90% loss for a year compared to 6-month loss of -2.07%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 107.30% gain in the last 1 month and extending the period to 3 months gives it a 107.30%, and is 95.86% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 25.68% over the week and 12.47% over the month.
ProKidney Corp (PROK) has around 163 employees, a market worth around $175.00M and $0.00M in sales. Distance from 52-week low is 153.57% and -78.98% from its 52-week high.
The EPS is expected to shrink by -67.37% this year
The shares outstanding are 59.88M, and float is at 43.22M with Short Float at 32.36%.
ProKidney Corp (PROK) Insider Activity
The most recent transaction is an insider sale by Weber Darin J., the company’s SVP of Regulatory Development. SEC filings show that Weber Darin J. sold 17,238 shares of the company’s common stock on Apr 16 ’24 at a price of $2.50 per share for a total of $43095.0. Following the sale, the insider now owns 0.17 million shares.
ProKidney Corp disclosed in a document filed with the SEC on Apr 12 ’24 that Weber Darin J. (SVP of Regulatory Development) sold a total of 84,103 shares of the company’s common stock. The trade occurred on Apr 12 ’24 and was made at $1.73 per share for $0.15 million. Following the transaction, the insider now directly holds 0.19 million shares of the PROK stock.
Still, SEC filings show that on Apr 01 ’24, Weber Darin J. (SVP of Regulatory Development) disposed off 300 shares at an average price of $1.69 for $507.0. The insider now directly holds 273,773 shares of ProKidney Corp (PROK).
